In a study of patients with non-small-cell lung cancer, flow cytometry and RNA analysis revealed that the percentage of circulating CD4 + and CD8 + T cells correlated with inflamed tumors, indicating that all of these markers play an important role in the anti-tumor responses [30]. This evidence concerns the gene CD4 and non-small cell lung carcinoma.